Advance Media Registration for BIO InvestorForum 2006 Now Available Online

WASHINGTON, D.C. (September 6, 2006) -- Media registration is now available for BIO InvestorForum 2006, to be held October 18-19, 2006 at the Palace Hotel in San Francisco.  Hosted by the Biotechnology Industry Organization (BIO), Rodman & Renshaw, Banc of America Securities, LLC, Jeffries & Company, Inc., and RBC Capital Markets, the investor meeting will showcase leading growth in companies in the life sciences. 

“The BIO InvestorForum 2006 is the foremost gathering of biotech industry executives and investors on the West Coast,” stated Alan Eisenberg, Executive Vice President, Emerging Companies and Business Development.  “Besides fantastic business opportunities, this meeting is an invaluable opportunity for senior executives to come together to discuss the latest issues and trends affecting the life sciences industry.”

The meeting will feature select company presentations, dynamic panel discussions and keynote talks on clinical strategy and product development along with insights on exciting new therapies and investment opportunities on the horizon.  Focusing on growth potential for both public and private companies, as well as the areas most likely to appear on the “growth watch list” in 2007, this year’s Therapeutic Workshops and CEO Roundtables promise to explore hot topics and debate the challenges facing the industry.  In attendance will be institutional investors, hedge fund managers, venture and private equity investors, as well as research analysts and bankers representing leading banks in the sector.  

Requested this year by sophisticated industry investors, the 2006 Therapeutic Workshop topics include:

·              Designing the Next Successful Cancer Drug in a Competitive Landscape

·              Redefining Alzheimer’s Disease with the Rise of New Disease-Modifying Drugs

·              New Advances in Therapies for a Growing Diabetes Epidemic

·              Evolving Treatments and Treatment Endpoints in Hepatitis C

·              Stopping Heart Failure:  The Promise of Current Research

·              Valuing Molecular Diagnostics – Today and in the Future

Based on popular demand, the slate of CEO Roundtable sessions this year includes:

·              The Next Biotech Winner:  Investment Characteristics that May Improve the Chances for Success in a High-Risk Industry

·              Public Investors Crossing Over to Invest in Private Opportunities – Separating Fact from Fiction

·              Is M&A and Licensing Good for the Biotech Industry?

·              Building Reimbursement Value Into Your Biotech Asset

Advance media registration for BIO InvestorForum 2006 is now available online. Registration is complimentary for credentialed members of the news media. To register, please visit http://investorforum.bio.org/opencms/bif/2006/Registration/media.jsp.   Only reporters and editors working full-time for print or broadcast news organizations may register onsite with valid media credentials. All freelancers and online publications must register in advance by Friday, October 6, 2006.

BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and 31 other nations. BIO members are involved in the research and development of healthcare, agricultural, industrial and environmental biotechnology products.

###